Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

Acquired haemophilia A (AHA) is a rare bleeding disorder caused by inhibitory
autoantibodies against coagulation factor VIII (FVIII). AHA is a disease that most commonly …

Acquired hemophilia A (AHA) is a rare bleeding disorder (1.4 per million inhabitants per
year) caused by neutralizing antibodies against factor VIII. Although uncommon, these …

Although abundant data confirm the efficacy and safety profile of the developed vaccines
against COVID-19, there are still some concerns regarding vaccination in high-risk …

Acquired hemophilia A (AHA), a rare but life-threatening disorder, most commonly occurs in
older people and during pregnancy. During the coronavirus disease 2019 (COVID-19) …

Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder. Various autoimmune
diseases, including AHA, have been reported to occur after the administration of mRNA …

While the global pandemic caused by severe acute respiratory syndrome coronavirus type 2
(SARS-CoV-2) is still ongoing and new virus variants are emerging, there is a universal …

Abstract Background Acquired hemophilia A (AHA) is a rare bleeding disorder that can lead
to spontaneous hemorrhage or bleeding induced by invasive procedures or trauma. We …

Interventions: Recombinant factor VIIa (NovoSeven®) was administered every 2 hours to
control the bleeding, alongside immunosuppression with methylprednisolone 1 mg/kg daily …